Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Tarnow Insider Profile
4 Followers
Michael Tarnow, Director at Xenon, holds 77.94K shares in Xenon (Ticker: XENE), holds 120.10K shares in CASI Pharmaceuticals (Ticker: CASI). Most recently, Michael Tarnow Bought ― shares of Xenon on May 20, 2021 for an estimated value of 30.61K.
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+35.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Michael Tarnow
Michael Tarnow's Trading History
Xenon
May 20, 2021
Director
Informative Buy
30.61K
$3.15M
CASI Pharmaceuticals
―
Director
―
$392.73K
List of latest transactions for each holding click on a transaction to see Michael Tarnow's performance on stock
You May Also Like
Michael Tarnow insider profile FAQ
What is the percentage of profitable transactions made by Michael Tarnow?
The percentage of profitable transactions made by Michael Tarnow is 64%.
What is the average return per transaction made by Michael Tarnow?
The average return per transaction made by Michael Tarnow is 35.10%.
What stocks does Michael Tarnow hold?
Michael Tarnow holds: XENE, CASI stocks.
What was Michael Tarnow’s latest transaction?
Michael Tarnow latest transaction was an Informative Buy of $30.61K.
What was Michael Tarnow's most profitable transaction?
Michael Tarnow’s most profitable transaction was an Informative Buy of XENE stock on October 29, 2020. The return on the trade was 223.80%.
What is Michael Tarnow's role in Xenon?
Michael Tarnow's role in Xenon is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.